Patents by Inventor Malgorzata Wygrecka

Malgorzata Wygrecka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a FXIIa-inhibitor in the treatment of renal fibrosis and/or chronic kidney disease
    Patent number: 11505619
    Abstract: The invention relates to an inhibitor of Factor XII (FXII) for use in treating or preventing chronic kidney disease, renal fibrosis, glomerulosclerosis, renal scarring, ischemia/reperfusion injury in native or transplant kidneys and/or acute kidney injury, a kit for use in treating or preventing chronic kidney disease, renal fibrosis, glomerulosclerosis, renal scarring, ischemia/reperfusion injury in native or transplant kidneys, acute kidney injury, renal fibrosis as a result of rejection of a kidney transplant/allograft, and/or fibrosis of a kidney transplant/allograft as a result of rejection or recurrent underlying disease comprising one inhibitor of Factor XII, and an anti-Factor XII (FXII) antibody or antigen binding fragment thereof for use in treating or preventing chronic kidney disease, renal fibrosis, glomerulosclerosis, renal scarring, ischemia/reperfusion injury in native or transplant kidneys and/or acute kidney injury comprising one inhibitor of Factor XII.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: November 22, 2022
    Assignee: CSL Limited
    Inventors: Malgorzata Wygrecka, Marc Nolte, Con Panousis
  • USE OF A FXIIA-INHIBITOR IN THE TREATMENT OF RENAL FIBROSIS AND/OR CHRONIC KIDNEY DISEASE
    Publication number: 20210070879
    Abstract: The invention relates to an inhibitor of Factor XII (FXII) for use in treating or preventing chronic kidney disease, renal fibrosis, glomerulosclerosis, renal scarring, ischemia/reperfusion injury in native or transplant kidneys and/or acute kidney injury, a kit for use in treating or preventing chronic kidney disease, renal fibrosis, glomerulosclerosis, renal scarring, ischemia/reperfusion injury in native or transplant kidneys, acute kidney injury, renal fibrosis as a result of rejection of a kidney transplant/allograft, and/or fibrosis of a kidney transplant/allograft as a result of rejection or recurrent underlying disease comprising one inhibitor of Factor XII, and an anti-Factor XII (FXII) antibody or antigen binding fragment thereof for use in treating or preventing chronic kidney disease, renal fibrosis, glomerulosclerosis, renal scarring, ischemia/reperfusion injury in native or transplant kidneys and/or acute kidney injury comprising one inhibitor of Factor XII.
    Type: Application
    Filed: December 14, 2018
    Publication date: March 11, 2021
    Inventors: Malgorzata WYGRECKA, Marc NOLTE, Con PANOUSIS
  • Factor XII inhibitors for treating interstitial lung disease
    Patent number: 9150638
    Abstract: The present invention provides methods for treating interstitial lung diseases, comprising administering to an individual an effective amount of an inhibitor of coagulation factor XII. The invention further provides uses and pharmaceutical kits for that treatment.
    Type: Grant
    Filed: April 1, 2011
    Date of Patent: October 6, 2015
    Assignee: Justus-Liebig-Universität Giessen
    Inventors: Ewa Jablonska, Klaus Preissner, Malgorzata Wygrecka
  • FACTOR XII INHIBITORS FOR TREATING INTERSTITIAL LUNG DISEASE
    Publication number: 20130095108
    Abstract: The present invention provides methods for treating interstitial lung diseases, comprising administering to an individual an effective amount of an inhibitor of coagulation factor XII. The invention further provides uses and pharmaceutical kits for that treatment.
    Type: Application
    Filed: April 1, 2011
    Publication date: April 18, 2013
    Applicant: JUSTUS-LIEBIG-UNIVERSITÄT GIESSEN
    Inventors: Ewa Jablonska, Klaus Preissner, Malgorzata Wygrecka